Startups

Yamo Pharmaceuticals

Yamo Pharmaceuticals develops L1-79, a medicine intended to treat the core symptoms of autism spectrum disorder.

Team

Eugene PrahinChief Administrative Officer

Tom MegerianCMO and EVP Clinical Development

Tracy FischerSVP Regulatory and Quality

Uyen NguyenVP Clinical Operations

$—Unknown date